Journal article
Artificial intelligence in inflammatory bowel disease endoscopy: implications for clinical trials
- Abstract:
- Artificial intelligence shows promise for clinical research in inflammatory bowel disease endoscopy. Accurate assessment of endoscopic activity is important in clinical practice and inflammatory bowel disease clinical trials. Emerging artificial intelligence technologies can increase efficiency and accuracy of assessing the baseline endoscopic appearance in patients with inflammatory bowel disease and the impact that therapeutic interventions may have on mucosal healing in both of these contexts. In this review, state-of-the-art endoscopic assessment of mucosal disease activity in inflammatory bowel disease clinical trials is described, covering the potential for artificial intelligence to transform the current paradigm, its limitations, and suggested next steps. Site-based artificial intelligence quality evaluation and inclusion of patients in clinical trials without the need for a central reader is proposed; for following patient progress, a second reading using AI alongside a central reader with expedited reading is proposed. Artificial intelligence will support precision endoscopy in inflammatory bowel disease and is on the threshold of advancing inflammatory bowel disease clinical trial recruitment.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.7MB, Terms of use)
-
- Publisher copy:
- 10.1093/ecco-jcc/jjad029
Authors
- Publisher:
- Oxford University Press
- Journal:
- Journal of Crohn's and Colitis More from this journal
- Volume:
- 17
- Issue:
- 8
- Pages:
- 1342–1353
- Place of publication:
- England
- Publication date:
- 2023-02-22
- Acceptance date:
- 2023-02-22
- DOI:
- EISSN:
-
1876-4479
- ISSN:
-
1873-9946
- Pmid:
-
36812142
Terms of use
- Copyright holder:
- Ahmad et al
- Copyright date:
- 2023
- Rights statement:
- © The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited
If you are the owner of this record, you can report an update to it here: Report update to this record